首页> 外文期刊>Yonsei Medical Journal >Higher Fatality for Severe Fever with Thrombocytopenia Syndrome Complicated by Hemophagocytic Lymphohistiocytosis
【24h】

Higher Fatality for Severe Fever with Thrombocytopenia Syndrome Complicated by Hemophagocytic Lymphohistiocytosis

机译:合并血小板减少症并发血小板减少症的重度发热致死率更高

获取原文
       

摘要

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious zoonosis caused by the SFTS virus. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome associated with excessive immune activation. Cytokine storms are often seen in both SFTS and HLH, resulting in rapid disease progression and poor prognosis. The aim of this study was to identify whether SFTS cases complicated by HLH are related to higher rates of mortality. Descriptive analysis of the frequency of clinical and laboratory data, complications, treatment outcomes, and HLH-2004 criteria was performed. Cases presenting with five or more clinical or laboratory findings corresponding to the HLH-2004 diagnostic criteria were defined as SFTS cases complicated by HLH. Eighteen cases of SFTS were identified during a 2-year study period, with a case-fatality proportion of 22.2% (4 among 18 cases, 95% confidence interval 9%–45.2%). SFTS cases complicated by HLH were identified in 33.3% (6 among 18 cases). A mortality rate of 75% (3 among 4 cases) was recorded among SFTS cases complicated by HLH. Although there were no statistically significant differences in outcomes, fatal cases exhibited more frequent correlation with HLH-2004 criteria than non-fatal cases [3/14 (21.4%) vs. 3/4 (75%), p =0.083]. In conclusion, the present study suggests the possibility that SFTS cases complicated by HLH are at higher risk of poor prognosis.
机译:血小板减少症候群(SFTS)的重度发烧是由SFTS病毒引起的新兴传染性人畜共患病。吞噬性淋巴细胞组织细胞增生症(HLH)是与过度免疫激活相关的威胁生命的综合征。 SFTS和HLH中均经常出现细胞因子风暴,导致疾病快速发展和预后不良。这项研究的目的是确定SFTS并发HLH病例是否与更高的死亡率相关。对临床和实验室数据,并发症,治疗结果以及HLH-2004标准的发生频率进行描述性分析。出现符合HLH-2004诊断标准的五个或更多临床或实验室检查结果的病例定义为SFTS并发HLH病例。在为期两年的研究中,确定了18例SFTS,病死率为22.2%(18例中4例,95%的置信区间9%–45.2%)。 SFTS并发HLH病例占33.3%(18例中有6例)。 SFTS合并HLH病例的死亡率为75%(4例中的3例)。尽管结局差异无统计学意义,但致命病例与HLH-2004标准的相关性高于非致命病例[3/14(21.4%)与3/4(75%),p = 0.083]。总之,本研究提示SFTS合并HLH的患者预后不良的风险更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号